Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!

被引：0
|
作者：
Koufakis, Theocharis [1 ]
Popovic, Djordje S. [2 ,3 ]
Papadopoulos, Christodoulos [4 ]
Giouleme, Olga [5 ]
Doumas, Michael [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Propedeut Dept Internal Med 2, Thessaloniki 54642, Greece
[2] Univ Novi Sad, Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[3] Univ Novi Sad, Med Fac, Novi Sad, Serbia
[4] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Dept Cardiol 3, Thessaloniki, Greece
[5] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Propedeut Dept Internal Med 2, Gastroenterol & Hepatol Div,Med Sch, Thessaloniki, Greece
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2024年 / 25卷 / 02期
关键词：
MAFLD; cardiovascular risk; MACE; pharmacotherapy; NONALCOHOLIC STEATOHEPATITIS;
D O I：
10.1080/14656566.2024.2312239
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：123 / 126
页数：4
相关论文
共 50 条
  • [1] Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
    Lanthier, Nicolas
    Delzenne, Nathalie
    CELLS, 2022, 11 (17)
  • [2] Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?
    Ma, Tianyi
    Yuan, Huawei
    Guo, Zhanfang
    LIVER INTERNATIONAL, 2024, 44 (11) : 3103 - 3104
  • [3] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    Cardiovascular Diabetology, 21
  • [4] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [5] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [6] Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
    Ismaiel, Abdulrahman
    Spinu, Mihail
    Leucuta, Daniel-Corneliu
    Popa, Stefan-Lucian
    Chis, Bogdan Augustin
    Stanculete, Mihaela Fadgyas
    Olinic, Dan Mircea
    Dumitrascu, Dan L.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [7] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [8] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    Hepatology International, 2023, 17 : 626 - 635
  • [9] METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE IDENTIFIES SUBJECTS WITH CARDIOVASCULAR RISK BETTER THAN NONALCOHOLIC FATTY LIVER DISEASE
    Chun, Ho Soo
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Yong-Ho
    Kim, Ji-Hye
    Lee, Minjong
    Kim, Seung Up
    HEPATOLOGY, 2022, 76 : S789 - S789
  • [10] Impact of Metabolic Syndrome and Metabolic Dysfunction-Associated Fatty Liver Disease on Cardiovascular Risk in People with and without Type 2 Diabetes
    Matsubayashi, Yasuhiro
    Fujihara, Kazuya
    Yamada, Mayuko H.
    Yaguchi, Yuta
    Yamamoto, Masahiko
    Ishiguro, Hajime
    Kitazawa, Masaru
    Iwanaga, Midori
    Yamada, Takaho
    Kodama, Satoru
    Sone, Hirohito
    DIABETES, 2022, 71
12345